Orders from 1390 SEK Free delivery from 2895 SEK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 2895 SEK

Substances · Cannabinoids (Indazole carboxamides)

MDMB-4en-PINACA

C20H27N3O3 CAS 2504100-70-1 Analytical reference material — not for human consumption
MDMB-4en-PINACA, educational illustration of the molecular structure
Educational illustration of the molecular structure. This is not a photograph of the product.
Preferred name
MDMB-4en-PINACA
IUPAC name
methyl (2S)-3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate
Parent CAS number (reference)
2504100-70-1
Molecular formula
C20H27N3O3
Molecular weight
357.4 g/mol
InChIKey
LWOCBHBFWNGPGM-QGZVFWFLSA-N
PubChem
CID 155804661
Source
PubChem
Verified synonyms & catalog abbreviations
4en-PINACA MDMB4enPINACA MDMB 4en PINACA

Verified Neurochemical & Toxicological Intelligence

MDMB-4en-PINACA (4en-PINACA / 5-CL-ADB-A)

Synthetic Cannabinoid Receptor Agonist (Potent Full CB1/CB2 Agonist) Indazole-3-carboxamide (pent-4-enyl tert-leucinate methyl ester)
Verified PubChem & CAS Identity C20H27N3O3 · CAS 2504100-70-1 · CID 155804661
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 357.45 g/mol
Peer-Reviewed & Agency Citations 4 · verified sources

Receptor Telemetry & Mechanism of Action

NMDA Uncompetitive Channel Blockade Primary
SERT / DAT Monoamine Reuptake Tone Low

Potent, efficacious **full agonist** at human CB1 receptors (Ki = 3.26 ± 0.81 nM in HEK cells; functional EC50 = 4.3 nM), replacing the 5-fluoropentyl tail of 5F-MDMB-PINACA with a terminal pent-4-en-1-yl alkene. The methyl 3,3-dimethylbutanoate ('MDMB') head moiety confers high CB1 potency and toxicity without THC's partial-agonist ceiling, interfering with hippocampal cognitive function and triggering heavy sedation or stimulation, dissociation, memory loss, agitation, and potentially fatal toxicity.

Biotransformation & Active Metabolites

Has an in vitro microsomal half-life of ~10 minutes, generating 14 metabolites; authentic human urine analyses identify dihydrodiol metabolite M3 (C19H27N3O5) and the ester-hydrolysis butanoic acid metabolite as primary biomarkers.

Temporal Pharmacokinetics

Rapid, overwhelmingly dense full-CB1 intoxication that shifts across a tiny microgram margin from cannabis-like mood elevation into dissociation, memory loss, confusion, agitation, or fatal coma.

  1. Onset 1–3 minutes inhaled (longer if swallowed)
  2. Peak Window 10–30 minutes inhaled
  3. Total Window 1–2 hours inhaled (up to 5–6 hours depending on amount and route)
  4. Residual / Half-Life 1–4 hours of cognitive fog and fatigue; in vitro t1/2 is ~10 minutes, with urinary metabolites detected within 1 hour.

EXTREME MICROGRAM HAZARD: WHO 43rd ECDD notes that the exact human pharmacological dose is unestablished, and EMCDDA stresses there is no antidote. Anchored to its 4.3 nM CB1 EC50 and WHO's 50 ug 5F-ADB benchmark, a single visible 1 mg (1,000 ug) speck of pure powder represents **multiple strong/overdose exposures**—making eyeballing potentially fatal and requiring strict volumetric liquid dilution.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
25–50 ug (0.025–0.05 mg — tentative microgram estimate)
Cognitive & Sensory

Subtle perceptual softening, mild mood shift, and early time-sense slowing.

Somatic & Autonomic

Faint bodily warmth and slight pulse shift.

Light
50–100 ug (0.05–0.10 mg — tentative microgram estimate)
Cognitive & Sensory

Cannabis-like mood elevation, sensory enhancement, and relaxed or mildly stimulated state.

Somatic & Autonomic

Dry mouth, conjunctival redness, and mild motor slowing.

Common Reference
100–250 ug (0.10–0.25 mg — tentative microgram estimate)
Cognitive & Sensory

Intense cannabimimetic intoxication, time dilation, short-term memory loss, and early dissociation.

Somatic & Autonomic

Marked sedation (or paradoxical stimulation), tachycardia, impaired balance, and dizziness.

Strong
250–400 ug (0.25–0.40 mg — tentative microgram estimate)
Cognitive & Sensory

Pronounced dissociation, confusion, agitation, acute anxiety/paranoia, and memory blackouts.

Somatic & Autonomic

Severe ataxia, nausea/vomiting, chest pounding, and tremors.

Heavy / Toxic Zone
400–500+ ug (0.40–0.50+ mg — tentative microgram estimate)
Cognitive & Sensory

Loss of consciousness/coma, severe delirium, acute psychosis, and complete amnesia.

Somatic & Autonomic

Vomiting with aspiration hazard, seizures, cardiovascular/renal toxicity, and documented fatal overdose.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Opioids (Fentanyl, Heroin, O-DSMT), Alcohol, Benzodiazepines, and GHB/GBL

WHO 43rd ECDD flags adulteration/co-exposure with opioids (fentanyl/heroin); combining full CB1 stupor and vomiting with CNS depressants causes fatal respiratory arrest and aspiration.

Other Synthetic Cannabinoids (e.g., 4F-ABUTINACA, 5F-MDMB-PINACA — confirmed in fatal autopsies)

Published post-mortem toxicology confirms dual-SCRA fatal overdoses from unpredictable full-CB1 cardiorespiratory collapse.

Stimulants / Cathinones (alpha-PiHP, Cocaine, Bupropion) and Lithium

Co-detected in forensic cases; compounds tachycardia, seizures, and acute psychotic delirium.

Elevated Hazard — Avoid

Psychedelics, Dissociatives, and Tramadol

Escalates severe dissociation, panic, confusion, and seizure susceptibility.

Caution / Receptor Attenuation

Botanical Cannabis (THC)

Never apply to or combine with cannabis flower—overrides THC's partial-agonist safety ceiling.

Structural Isomer & Sibling Comparison

MDMB-4en-PINACA (CB1 Ki = 3.26 nM, EC50 = 4.3 nM, alkene tail) is ~7-fold higher in numeric EC50 (less potent in vitro) than fluorinated 5F-MDMB-PINACA (EC50 0.59 nM) and ADB-PINACA (EC50 0.52 nM), while slightly more potent in EC50 than ADB-BUTINACA (EC50 6.36–11.5 nM) and beta-arrestin assays of 4F-MDMB-BINACA (5.69–7.39 nM). All six remain microgram-active full CB1 agonists vastly stronger and riskier than botanical Banana Haze flower.

Physicochemical Stability & Storage

Physical Form: White, yellow, brown, or tan neat powder or solid (NEVER supplied on sprayed herbs). · Soluble in chloroform, methanol, ethanol, DMF, and DMSO; only partially soluble in water.

Store sealed, dry, and protected from light in a cool or frozen container.

Cross-Tolerance & Dependence Profile

Dose- and duration-dependent physical dependence and rapid CB1 cross-tolerance across all cannabinoids; abrupt cessation after frequent use causes anxiety, insomnia, nausea, and sweating.

Codes on this card

Short meanings for the abbreviations printed with this substance.

Open the full glossary →
DAT Dopamine transporter

DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.

SERT Serotonin transporter

SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.

NMDA NMDA glutamate channel

NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.

CB₁ / CB₂ Cannabinoid receptors CB1 and CB2

CB1 and CB2 are the two cannabinoid receptors named on these cards. Papers usually discuss CB1 in the nervous system and CB2 more often in immune tissue. The number beside them is often a Ki in nanomoles.

EC₅₀ / IC₅₀ Halfway concentration

EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.

Kᵢ Binding tightness in nanomoles

Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.

ratio Selectivity ratio

A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.

5-HT ↑↑ Serotonergic Overload (Serotonin Toxicity)

A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

Comprehensive Analytical & Toxicological Monograph

MDMB-4en-PINACA (5-CL-ADB-A; methyl (2S)-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate; CAS 2504100-70-1, PubChem CID 155804661) is an indazole-3-carboxamide synthetic cannabinoid supplied strictly as pure analytical powder or solid (`pure_powder_or_crystal`, C20H27N3O3, 357.45 g/mol — never as sprayed herbal mixtures). Replacing the 5-fluoropentyl chain of 5F-MDMB-PINACA with a terminal pent-4-en-1-yl alkene preserves nanomolar affinity and full efficacy at human CB1 receptors (Ki = 3.26 nM; EC50 = 4.3 nM). Unlike natural Delta9-THC in Banana Haze flower (a partial agonist with a safety ceiling), MDMB-4en-PINACA lacks any receptor ceiling and impairs hippocampal cognitive function. Both the WHO 43rd ECDD and EUDA/EMCDDA note that no safe clinical human quantitative brackets is established and no antidote exists; tentative microgram harm-reduction estimates anchored to its CB1 EC50 and WHO's 50 ug 5F-ADB benchmark place inhaled threshold activity around 25–50 ug, light mood elevation at 50–100 ug, common intense intoxication at 100–250 ug, strong dissociation, memory loss, and agitation at 250–400 ug, and potentially lethal overdose above 400–500 ug (0.4–0.5 mg). Because a single 1 mg powder grain represents multiple strong exposures, 'eyeballing' pure powder is life-threatening and requires precision volumetric dilution. Inhaled effects begin within minutes and typically last 1–2 hours. In vitro, MDMB-4en-PINACA is less extreme than 5F-MDMB-PINACA (0.59 nM) and ADB-PINACA (0.52 nM) and comparable to 4F-MDMB-BINACA and ADB-BUTINACA. Never mix with opioids, alcohol, benzodiazepines, GHB/GBL, other synthetic cannabinoids, stimulants, or lithium.

Chemical Architecture & Structural Profile

MDMB-4en-PINACA (methyl (2S)-3,3-dimethyl-2-[(1-pent-4-enylindazole-3-carbonyl)amino]butanoate) is a reference compound belonging to the Cannabinoids (Indazole carboxamides) class, characterized by the molecular formula C20H27N3O3 and a molar mass of 357.4 g/mol. The parent molecule is indexed under CAS registry number 2504100-70-1 and in the NCBI PubChem database as CID 155804661 (Standard InChIKey: LWOCBHBFWNGPGM-QGZVFWFLSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), MDMB-4en-PINACA is indexed within the Cannabinoids (Indazole carboxamides) structural group. Synthetic indazole carboxamide exhibiting high receptor affinity in in-vitro assays; requires calibrated micro-analytical balances and full dermal and respiratory protection. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations